89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
14.87
+0.02 (0.10%)
Oct 6, 2025, 2:00 PM EDT - Market open
89bio Market Cap
89bio has a market cap or net worth of $2.21 billion as of October 6, 2025. Its market cap has increased by 150.80% in one year.
Market Cap
2.21B
Enterprise Value
1.68B
1-Year Change
150.80%
Ranking
Category
Stock Price
$14.87
Market Cap Chart
Since November 12, 2019, 89bio's market cap has increased from $256.62M to $2.21B, an increase of 760.17%. That is a compound annual growth rate of 44.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 2.21B | 139.82% |
| Dec 31, 2024 | 919.49M | -11.68% |
| Dec 29, 2023 | 1.04B | 75.74% |
| Dec 30, 2022 | 592.42M | 123.48% |
| Dec 31, 2021 | 265.09M | -45.28% |
| Dec 31, 2020 | 484.45M | 33.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |